Lenox Hill conducts VENUS clinical trial for knee pain implant: 6 observations

Megan Wood -   Print  |

Lenox Hill Hospital in New York is conducting a VENUS clinical trial for Active Implants' NUsurface Meniscus Implant. Active Implants is an orthopedic implant solutions company.

Here are six observations:


1. The implant is designed to help patients with persistent knee pain after medial meniscus surgery.


2. The NUsurface is composed of medical grade plastic and doesn't need fixation to bone or tissue. Surgeons place the implant into the knee joint.


3. There are 10 sites across the nation conducting the VENUS clinical trial.


4. The study will involve about 130 patients in the United States, Europe and Israel.


5. Participants will be between the ages of 30 and 75 and experience pain after medial meniscus surgery performed at least six months prior to the study.


6. The implant has been used clinically in Europe since 2008.


"Damage to the meniscus can lead to arthritis and the need for knee replacement surgery," said Elliott Hershman, MD, chairman of orthopedic surgery at Lenox Hill Hospital. "We hope this study finds that the NUsurface implant alleviates pain in these patients, as well as helps them delay or avoid knee replacement surgery."


More articles on devices:
500th Navio knee surgery performed at Cornerstone Regional Hospital: 5 key notes
Alphatec Spine, LDR, Globus Medical & more — 21 key notes
DJO Surgical unveils its EMPOWR 3D Knee system: 5 points

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers